Protein/protein interaction (PPI) interfaces have emerged as drug targets to develop medications with less side effects. Here, Dvorak et al. show that small molecule targeting of PPIs in the brain is an approach for psychiatric drug discovery.
- Nolan M. Dvorak
- Paul A. Wadsworth
- Fernanda Laezza
